Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Noemie Leblay"'
Autor:
Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noemie Leblay, Graham Byrnes, Ruping Sun, Aurélien De Reynies, Anne McLeer-Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James D. McKay, Denis Moro-Sibilot, Christian G. Brambilla, Sylvie Lantuejoul, Nicolas Lemaitre, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund-Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, David Neil Hayes, Elisabeth Brambilla, Lynnette Fernandez-Cuesta, Roman K. Thomas
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
The molecular nature of large-cell neuroendocrine lung carcinomas (LCNEC) has remained unclear. Here, the authors show LCNECs represent a distinct transcriptional subgroup among lung cancers and comprise two molecular subgroups, type I (TP53 and STK1
Externí odkaz:
https://doaj.org/article/0b984304ba014836a34f2b6d1a57b335
Autor:
Lynnette Fernandez-Cuesta, Sandra Perdomo, Patrice H. Avogbe, Noemie Leblay, Tiffany M. Delhomme, Valerie Gaborieau, Behnoush Abedi-Ardekani, Estelle Chanudet, Magali Olivier, David Zaridze, Anush Mukeria, Marta Vilensky, Ivana Holcatova, Jerry Polesel, Lorenzo Simonato, Cristina Canova, Pagona Lagiou, Christian Brambilla, Elisabeth Brambilla, Graham Byrnes, Ghislaine Scelo, Florence Le Calvez-Kelm, Matthieu Foll, James D. McKay, Paul Brennan
Publikováno v:
EBioMedicine, Vol 10, Iss C, Pp 117-123 (2016)
Circulating tumor DNA (ctDNA) is emerging as a key potential biomarker for post-diagnosis surveillance but it may also play a crucial role in the detection of pre-clinical cancer. Small-cell lung cancer (SCLC) is an excellent candidate for early dete
Externí odkaz:
https://doaj.org/article/972ad8bc7ce64e1fa920ebbb396ad74b
Autor:
Holly Lee, Paola Neri, Sungwoo Ahn, Ranjan Maity, Noemie Leblay, Bachisio Ziccheddu, Monika Chojnacka, Rémi Tilmont, Elie Barakat, Ola Landgren, Francesco Maura, Nizar Jacques Bahlis
Publikováno v:
Blood. 140:252-253
Autor:
Remi Tilmont, Ranjan Maity, Noemie Leblay, Holly Lee, Elie Barakat, Paola Neri, Nizar J. Bahlis
Publikováno v:
Blood. 140:9964-9965
Autor:
Paola Neri, Sungwoo Ahn, Holly Lee, Noemie Leblay, Mirco Friedrich, Ranjan Maity, Rémi Tilmont, Elie Barakat, Marc S Raab, Nizar Jacques Bahlis
Publikováno v:
Blood. 140:2093-2094
Publikováno v:
HemaSphere, Vol 5, Iss 6, p e575 (2021)
HemaSphere
HemaSphere
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Immunotherapy has recently emerged as a promising treatment option for multiple myeloma (MM) patients. Profound immune dysfunction and evasion of immune surveillance are known to characterize MM evolution and disease progression. Along with genomic c
Autor:
Marc-Steffen Raab, Niels Weinhold, Julius Michel, Paola Neri, Nizar J. Bahlis, Michael Platten, Elie Barakat, Niklas Kehl, Sungwoo Ahn, Hartmut Goldschmidt, Mirco Friedrich, Noemie Leblay, Holly Lee
Publikováno v:
Blood. 138:731-731
Immunotherapies have transformed the clinical care of patients with cancer. Bispecific T cell engagers (TCEs) have recently entered early-phase clinical trials of multiple myeloma (MM) and shown remarkable response rates even in heavily pretreated pa
Autor:
Paola Neri, Nizar J. Bahlis, Elie Barakat, Holly Lee, Sungwoo Ahn, Ranjan Maity, Noemie Leblay
Publikováno v:
Blood. 138:725-725
Multiple myeloma is characterized by recurrent chromosomal translocations that involve the immunoglobulin gene enhancers and partners such as the cyclin D genes (CCND1, CCND2 or CCND3) or other genes like WHSC1 and MAF. t(11;14) results in upregulati
Autor:
Ranjan Maity, Sacha Benaoudia, Franz Zemp, Holly Lee, Elie Barakat, Noemie Leblay, Sungwoo Ahn, Douglas Mahoney, Paola Neri, Nizar J. Bahlis
Publikováno v:
Blood. 138:327-327
Chimeric antigen receptor (CAR) T cells targeting the B-cell maturation antigen (BCMA) have resulted in deep responses in patients with relapsed MM however most remissions are not sustained. While cellular and molecular mediators of relapse post CAR